50 related articles for article (PubMed ID: 26492057)
1. Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.
Lv Y; Yao X; Ling Q; Suo S; Wang J; Zhao S; Gao X; Tong H; Jin J; Zhang X; Yu W
Ann Hematol; 2024 Jan; 103(1):357-360. PubMed ID: 37777636
[No Abstract] [Full Text] [Related]
2. A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.
Coltro G; Santi R
Blood; 2023 May; 141(20):2541. PubMed ID: 37200055
[No Abstract] [Full Text] [Related]
3. FIP1L1::PDGFRA fusion driving three synchronous haematological malignancies.
Krigstein M; Menzies A; Fay K; Lukeis R; Cheung K; Parker A
Pathology; 2023 Dec; 55(7):1040-1044. PubMed ID: 37563028
[No Abstract] [Full Text] [Related]
4. [Treatment of adult acute lymphoblastie leukemia with eosinophilia and abnormality of PDGFRA by autologous hematopoietic stem cell transplantation and imatinib: one case report and literatures review].
Shi Y; Yang D; Liu Q; He Y; Zhang R; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):866-7. PubMed ID: 26477768
[No Abstract] [Full Text] [Related]
5. Hypereosinophilic syndrome with eosinophilic cystitis in children.
Shang M; Gao L; Zhang Y; Ding H
Pediatr Int; 2024; 66(1):e15701. PubMed ID: 38217096
[No Abstract] [Full Text] [Related]
6. Biventricular Endomyocardial Fibrosis in a Patient With Chronic Myeloid Leukemia-Classical Imaging Diagnosis Not to Be Missed.
Shams P; Tipoo Sultan FA
CASE (Phila); 2024 Mar; 8(3Part B):249-252. PubMed ID: 38524884
[TBL] [Abstract][Full Text] [Related]
7. French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Groh M; Rohmer J; Etienne N; Abou Chahla W; Baudet A; Chan Hew Wai A; Chenivesse C; Clisson Rusek I; Cottin V; Decamp M; De Groote P; Delahousse F; Duployez N; Faguer S; Gottrand F; Huang F; Leblanc T; Magnan A; Martin T; Mortuaire G; Néel A; Paris L; Petit A; Rossignol J; Schleinitz N; Soret-Dulphy J; Staumont-Salle D; Terrier B; Terriou L; Viallard JF; Lefèvre G; Kahn JE
Orphanet J Rare Dis; 2023 Apr; 18(1):100. PubMed ID: 37122022
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.
Ammirati E; Bizzi E; Veronese G; Groh M; Van de Heyning CM; Lehtonen J; Pineton de Chambrun M; Cereda A; Picchi C; Trotta L; Moslehi JJ; Brucato A
Front Med (Lausanne); 2022; 9():838564. PubMed ID: 35350578
[TBL] [Abstract][Full Text] [Related]
9. Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicity.
Arai A; Yan W; Wakabayashi S; Hayashi S; Inazawa J; Miura O
Int J Hematol; 2007 Oct; 86(3):233-7. PubMed ID: 17988989
[TBL] [Abstract][Full Text] [Related]
10. FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.
Cools J
Verh K Acad Geneeskd Belg; 2005; 67(3):169-76. PubMed ID: 16089297
[TBL] [Abstract][Full Text] [Related]
11. Successful Heart Transplantation for Unreversible Endomyocardial Fibrosis Related to FIP1L1-PDGFRA Chronic Eosinophilic Leukemia.
Fassnacht F; Roumier M; Fouret P; Levy V; Varnous S; Russel S; Lefevre G; Kahn JE
Transplantation; 2015 Nov; 99(11):e176-7. PubMed ID: 26492057
[No Abstract] [Full Text] [Related]
12. Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript.
Helbig G; Soja A; Świderska A; Hus M; Kyrcz-Krzemień S
Leuk Lymphoma; 2016; 57(3):708-10. PubMed ID: 26430910
[No Abstract] [Full Text] [Related]
13. Imatinib Treatment of Lymphomatoid Papulosis Associated with Myeloproliferative Hypereosinophilic Syndrome Presenting the FIP1L1-PDGFRA Fusion Gene.
García-Martínez P; Sitjas D; Llistosella E; Espinet B; Rodríguez-Rivera M; Hernandez-Muñoz M; Gallardo F; Pujol RM
Acta Derm Venereol; 2017 Jul; 97(7):855-857. PubMed ID: 28374041
[No Abstract] [Full Text] [Related]
14. [Endomyocardial fibrosis in chronic eosinophilic leukemia].
Winter L; Zellweger MJ; Bremerich J
Rofo; 2009 Jul; 181(7):691-3. PubMed ID: 19401974
[No Abstract] [Full Text] [Related]
15. Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.
Helbig G; Kyrcz-Krzemień S
Am J Hematol; 2014 Jan; 89(1):115. PubMed ID: 24009127
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
